Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in non-hospitalized COVID-19 patients
NCT04371952Phase 3Withdrawn
- Sponsor
- CHU de Nantes
- Start
- Feb 2021
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxycycline in coronavirus disease 2019 (COVID-19), sponsored by CHU de Nantes. Planned start Feb 2021; status: withdrawn.
02
Drugs
doxycycline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04371952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04371952.